Unraveling hemophilic arthropathy

Blood

Volumn 117, Issue 8, 2011, Pages 2302-2303

  Abshire, Thomas ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTHROPATHY; BLEEDING; DISEASE ASSOCIATION; HEMOPHILIA; HEMOPHILIC ARTHROPATHY; HUMAN; NOTE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 79952160662     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-01-327312     Document Type: Note

References (6)

1. Acharya SS, Kaplan RN, Macdonald D, Fabiyi OT, DiMichele D, and Lyden D. Neoangiogenesis contributes to the development of hemophilic synovitis. Blood. 2011;117(8):2484-2493.
2. Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.NEngl J Med. 2007; 357(6):535-544. (Pubitemid 47236278)
3. Dunn AL, Busch MT, Wyly JB, et al. Arthroscopic synovectomy for hemophilic joint disease in a pediatric population. J Pediatr Orthop. 2004;24(4):414-426. (Pubitemid 38857543)
4. Wen FQ, Jabbar AA, Chen YX, et al. c-myc protooncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide. Blood. 2002; 100(3):912-916. (Pubitemid 34832617)
5. Hakobyan N, Kazarian T, Jabbar AA, et al. Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene. Blood. 2004;104(7):2060-2064. (Pubitemid 39297857)
6. Roosendaal G, Vianen ME, Wenting MJ, et al. Iron deposits and catabolic properties of synovial tissue from patients with haemophilia. J Bone Joint Surg Br. 1998; 80(3):540-545.